Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China flag China · Delayed Price · Currency is CNY
16.62
+0.22 (1.34%)
Aug 27, 2026, 1:35 PM CST

SHA:600521 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
624266.41,119830.471,168487.54
Depreciation & Amortization
1,061998.02916.77780.37672.01563.07
Other Amortization
19.0726.6915.89.257.082.45
Loss (Gain) From Sale of Assets
-23.35-0-2.330.29-3.59-0.6
Asset Writedown & Restructuring Costs
61.8953.630.1339.4121.6910.35
Loss (Gain) From Sale of Investments
-259.97-69.4597.72161.9766.48-442.95
Provision & Write-off of Bad Debts
-21.62-9.0336.58-7.9345.3714.73
Other Operating Activities
456.92393.59229.27241.6986.91220.3
Change in Accounts Receivable
46.49-126.34-786.09269.5-818.89-388.87
Change in Inventory
-139.26-471.61-78.33-140.05-679.92-386.81
Change in Accounts Payable
122.08165.02597.6819.99669.89679.92
Change in Other Net Operating Assets
9.38.3114.14-0.4981.61113.74
Operating Cash Flow
1,9591,2302,1732,2171,243938.43
Operating Cash Flow Growth
57.38%-43.38%-2.00%78.41%32.42%-39.67%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,918-1,966-1,853-1,592-2,316-2,434
Sale of Property, Plant & Equipment
34.589.955.24.8410.729.94
Cash Acquisitions
-6.53-----
Investment in Securities
118.4186.27-72.57-18.7-106.6658.19
Other Investing Activities
2.122.280.43-16.53-20.359.48
Investing Cash Flow
-1,617-1,868-1,920-1,623-2,433-2,357

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-4,7266,2023,3213,8733,238
Long-Term Debt Repaid
--4,337-5,637-3,321-2,732-1,931
Net Debt Issued (Repaid)
773.81388.58564.79-0.61,1401,307
Issuance of Common Stock
-591.52--37.68371.82
Repurchase of Common Stock
---189.92-71-172.43-150.01
Common Dividends Paid
-697.07-546.18-475.36-556.01-318.32-387.21
Other Financing Activities
-40.29183.16-32.42-16.63-78.36-23.31
Financing Cash Flow
36.44617.07-132.91-644.23609.041,118

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-125.28-10.6551.162954.65-43.49
Net Cash Flow
252.24-31.05170.63-20.98-526.18-343.57

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
40.26-735.96319.33624.63-1,074-1,496
Free Cash Flow Growth
---48.88%---
Free Cash Flow Margin
0.45%-8.57%3.35%7.52%-12.99%-22.52%
Free Cash Flow Per Share
0.03-0.500.220.43-0.73-1.04
Levered Free Cash Flow
-238.23-887.07-478.3615.26-1,715-1,721
Unlevered Free Cash Flow
-164.91-741.07-340.99160.07-1,578-1,617

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-0.060.060.060.060.06
Cash Income Tax Paid
233.92391.44568.31614.3206.43227.84
Change in Working Capital
40.27-429.72-270.27161.5-821.0283.55